Projects per year
Personal profile
Education
- 2018.09-2024.01 Ph.D., Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University
- 2001.09-2008.06 M.D., School of Medicine, Kaohsiung Medical University
Experience
- 2025.02- Director, Division of Thoracic Medicine, Department of Internal Medicine, Taipei Medical University Hospital
- 2024.11- Assistant professor, School of Respiratory Therapy, Taipei Medical University
- 2024.08-2025.01 Acting Director, Division of Thoracic Medicine, Department of Internal Medicine, Taipei Medical University Hospital
- 2015.01- Attending physician, Division of Pulmonary Medicine, Department of Internal Medicine, Taipei Medical University Hospital
- 2012.07-2014.12 Chief Resident, Division of Pulmonary Medicine, Department of Internal Medicine, Taipei Medical University Hospital
- 2009.07-2012.06 Resident Physician, Department of Internal Medicine, Taipei Medical University Hospital
Research Interests
- Lung cancer
- COPD
- Asthma
- Interstitial lung disease
- pleural effusion
Fingerprint
Dive into the research topics where Kai-Ling Lee is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Active
-
新聘教師研究補助
Lee, K.-L. (PI)
1/20/26 → 1/19/27
Project: B - Project of TMU › g - Research Grants for Newly Hired Faculty
-
The off‑target effect of loratadine triggers autophagy‑mediated apoptosis in lung adenocarcinoma cells by deactivating JNK, p38, and STAT3 signaling through both PP2A‑dependent and independent pathways
Chien, M. H., Hung, W. Y., Lai, T. C., Tsai, C. H., Lee, K. L., Hsieh, F. K., Lee, W. J. & Chang, J. H., Apr 2025, In: International Journal of Molecular Medicine. 55, 4, 54.Research output: Contribution to journal › Article › peer-review
5 Link opens in a new tab Citations (Scopus) -
Effectiveness of Stereotactic Ablative Radiotherapy for Systemic Therapy Respondents with Inoperable Pulmonary Oligometastases and Oligoprogression
Ho, C. B., Tsai, J. T., Chen, C. Y., Shiah, H. S., Chen, H. Y., Ting, L. L., Kuo, C. C., Lai, I. C., Lai, H. Y., Chung, C. L., Lee, K. L., Tzeng, H. E., Lee, K. H., Lee, H. L., Chen, S. W. & Chiou, J. F., May 2023, In: Diagnostics. 13, 9, 1597.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Citations (Scopus) -
IL-17A induces EGFR-targeted therapy resistance via enhancing EGFR activation in lung cancer
Lee, K. L., Chung, C.-L. & Chien, M.-H., Oct 2023.Research output: Contribution to conference › Abstract › peer-review
-
Sustaining the Activation of EGFR Signal by Inflammatory Cytokine IL17A Prompts Cell Proliferation and EGFR-TKI Resistance in Lung Cancer
Lee, K.-L., Lai, T. C., Lee, W.-J., Chen, Y.-C., Ho, K.-H., Hung, W.-Y., Yang, Y.-C., Chan, M.-H., Hsieh, F.-K., Chung, C.-L., Chang, J.-H. & Chien, M.-H., Jun 22 2023, In: Cancers. 15, 13Research output: Contribution to journal › Article › peer-review
12 Link opens in a new tab Citations (Scopus) -
Toll-like Receptor 2 Mediates VEGF Overexpression and Mesothelial Hyperpermeability in Tuberculous Pleural Effusion
Chen, W. L., Lee, K. L., Lai, K. S., Tsai, J. H., Hsiao, S. H. & Chung, C. L., Feb 2023, In: International journal of molecular sciences. 24, 3, 2846.Research output: Contribution to journal › Article › peer-review
Open Access5 Link opens in a new tab Citations (Scopus)